Magnetic Resonance Imaging News and Research

RSS

Magnetic resonance imaging (MRI) is an imaging technique which physicians use for the diagnosis and treatment of medical conditions.

Study uncovers pathogenic variants in the chromatin modifier EZH1 as the cause of neurodevelopmental disorders

Study identified pathogenic variants in the EZH1 as a cause of neurodevelopmental disorders.

14 Jul 2023

Study identifies a signature of risk for developing hypomania

Mania, in which mood and energy level are extremely elevated for at least a week, and hypomania, which is less severe and lasts at least four days, are the defining features of bipolar spectrum disorders (BSD) and can be the most disruptive symptoms.

11 Jul 2023

Study provides unprecedented insights into the complexity of large-scale neural networks

That experiences leave their trace in the connectivity of the brain has been known for a while, but a pioneering study by researchers at the German Center for Neurodegenerative Diseases (DZNE) and TUD Dresden University of Technology now shows how massive these effects really are.

11 Jul 2023

Biomarkers in the brain could redefine mental health conditions

The study of biomarkers in the brain-;powered by cutting-edge machine learning techniques-;could redefine the way mental health conditions are categorized and diagnosed and lead to more effective, personalized treatments.

10 Jul 2023

Abnormal cortical folding linked to major depressive disorder

Major depressive disorder (MDD) is a complex and debilitating metal illness. Given its complex and widespread nature, MDD has been a subject of intense medical research.

10 Jul 2023

COST Connect: A platform for collaboration and progress in cancer research

Beating cancer is a major challenge for research and innovation in the coming years. By 2030, it is estimated that over 1.5 million people in the EU will succumb to cancer.

6 Jul 2023

Critical questions raised for evaluation of anti-amyloid immunotherapies in Alzheimer's treatment

Anti-amyloid immunotherapies for Alzheimer's disease require thorough evaluation of their efficacy, safety, and cost-effectiveness. Key questions regarding statistical analyses, treatment effects, and disease course modification guide evidence-based consideration of these drugs.

4 Jul 2023

New biomarker for major depressive disorder identified

In appearance, the human brain's outermost layer, called the cortex, is a maze of tissue folds. The peaks or raised surfaces of these folds, called gyri, play an important role in the proper functioning of the brain.

4 Jul 2023

20 years later: lessons from SARS-CoV-2 inform preparedness against future pandemics

The identification, development, and assessment of medical countermeasures against emerging pathogens.

30 Jun 2023

Research sheds light on genetic variants' impact beyond autism diagnosis

Scientists conducted the largest meta-analysis to elucidate the phenotypes of ASD-diagnosed individuals .

30 Jun 2023

Using the power of machine learning to develop a predictive model of rumination

Our minds often get trapped in repetitive thoughts, such as past mistakes, regrets, insecurities, or unresolved conflicts.

29 Jun 2023

Lonely people process the world differently, study finds

The Russian writer and philosopher Leo Tolstoy may have been onto something when he wrote the opening line of Anna Karenina: "Happy families are all alike; every unhappy family is unhappy in its own way."

28 Jun 2023

AI model can help doctors determine the extent of cancer within the prostate

A new study shows that an artificial intelligence (AI) model co-developed by researchers in the UCLA Jonsson Comprehensive Cancer Center and department of Urology at UCLA can help doctors determine the extent of cancer within the prostate.

27 Jun 2023

Multiple subtypes of major depressive disorder identified using brain imaging

Major depressive disorder (MDD) is not only among the most common mental illnesses, affecting over 8% of Americans, but it is also extremely variable from one person to another.

27 Jun 2023

University Hospital Bonn and DZNE receive prestigious "Ataxia Center of Excellence" award

The Ataxia Center at the University Hospital Bonn (UKB) and DZNE have been awarded the title "Ataxia Center of Excellence" by the US National Ataxia Foundation (NAF) for their patient care and research – as the only organization in Europe.

26 Jun 2023

New category of depression identified

Scientists at Stanford Medicine conducted a study describing a new category of depression -; labeled the cognitive biotype -; which accounts for 27% of depressed patients and is not effectively treated by commonly prescribed antidepressants.

23 Jun 2023

Study finds the risk of recurrence of active disease in older patients with MS after discontinuing therapy

An article published today in the journal Lancet Neurology evaluates the risk of recurrence of active disease in older patients with multiple sclerosis after discontinuing disease-modifying therapies.

23 Jun 2023

Cardiac MRI is a safe and valuable tool to help evaluate patients with acute chest pain

An estimated 3 million patients visit emergency departments each year with acute chest pain and mildly elevated troponin levels.

20 Jun 2023

Study proposes an efficient algorithm for fully automatic 3D left atrial segmentation

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Studying atrial structure directly is crucial for comprehending and managing atrial fibrillation (AF).

19 Jun 2023

Type 2 diabetes takes a toll on the brain altering microstructure

Type 2 diabetes patients exhibit brain tissue damage in mood and cognitive regions, impacting their functions. Diffusion tensor imaging reveals chronic tissue changes in various brain areas, such as the cerebellum and frontal cortex, correlating with mood and cognitive symptoms.

18 Jun 2023